- Home
- HYPR vs OM Comparison
HYPR vs OM Comparison
Compare HYPR & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYPR | OM |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 85.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | HYPR | OM |
|---|---|---|
| Price | $1.07 | $3.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.28 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 800.6K | 480.1K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,591,000.00 | ★ $120,069,000.00 |
| Revenue This Year | $5.17 | $5.77 |
| Revenue Next Year | $35.44 | $9.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $0.53 | $3.32 |
| 52 Week High | $2.22 | $25.35 |
Technical Indicators
Market Signals| Indicator | HYPR | OM |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 21.34 |
| Support Level | $0.91 | $3.66 |
| Resistance Level | $1.18 | $3.83 |
| Average True Range (ATR) | 0.08 | 0.29 |
| MACD | 0.02 | 0.19 |
| Stochastic Oscillator | 59.26 | 1.75 |
Price Performance
Historical ComparisonAbout HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.